Mineralys Therapeutics (MLYS) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Mineralys Therapeutics.
Bought (12 mo)
$8,762,797
Sold (12 mo)
$88,004,683
Insiders Buying (12 mo)
5
Insiders Selling (12 mo)
8
Form 4 Filings (All Time)
162
Most Recent Purchase
March 31, 2026
Ra Capital Management, L.P.
Director
$8,762,797
Most Recent Sale
October 2, 2026
Jon Congleton
CEO
$1,909,665
Buys (90d)
0
Sells (90d)
6
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-10-20 | Coats Lonnel | Director | Award | — | — |
| 2026-10-20 | Peterson Kristine | Director | Award | — | — |
| 2026-10-02 | Congleton Jon | CEO | Sell | $1,909,665 | -12.4% |
| 2026-09-25 | Slingsby Brian Taylor | Director | Sell | $3,005,303 | -1.3% |
| 2026-09-22 | Warren Eric | Officer | Sell | $209,136 | — |
| 2026-09-17 | Karydas Daphne | Director | Sell | $85,740 | — |
| 2026-08-25 | Warren Eric | Officer | Sell | $193,189 | — |
| 2026-08-12 | Ferguson James J. Iii | Officer | Award | — | — |
| 2026-08-12 | Rodman David Malcom | Officer | Sell | $58,785 | — |
Sign up free to view more insider trades.